Newborn Bloodspot Screening condition assessment summary – congenital adrenal hyperplasia
This document is a summary of the evidence used to provide a national recommendation on adding congenital adrenal hyperplasia to Australian newborn bloodspot screening programs.
Downloads
Newborn Bloodspot Screening condition assessment summary – congenital adrenal hyperplasia
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Congenital adrenal hyperplasia (CAH) is a rare genetic condition that affects around 1 in 15,000 people in Australia. The condition affects the production of hormones from the adrenal glands.
This report outlines the evidence used to provide a national recommendation on adding CAH to Australian newborn bloodspot screening programs. It recommends adding CAH to the programs.